Interpretation Early integration of durvalumab-based immunotherapy with close MDT reassessment appears to expand curative-intent eligibility, offering a potential bridge between the AEGEAN perioperative and PACIFIC post-CRT paradigms
Individuals with a history of proliferative disorders or those taking complex polypharmacy regimens must consult an oncologist or internal medicine specialist prior to use
(This study needs some review and scrutiny, but that is for another post)
Its more than a beauty supplementits a health essential
ShedRx is worth it for users seeking weight-loss support through personalized meal plans, coaching, and community engagement
Paclitaxel is the most commonly used drug across cancer types, especially in BC, prostate cancer and lung squamous cell carcinoma, and is often combined with chlorpromazine and carboplatin